PsyBio Therapeutics Corp.
PSYBF
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.90M | -4.11M | -4.89M | -6.24M | -7.63M |
| Total Depreciation and Amortization | 114.00K | 152.00K | 152.00K | 114.00K | 76.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -611.20K | 529.60K | 686.00K | 1.11M | 1.70M |
| Change in Net Operating Assets | 805.20K | 896.90K | 610.90K | -480.60K | -501.50K |
| Cash from Operations | -1.59M | -2.53M | -3.44M | -5.49M | -6.36M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 857.30K | 2.24M | 3.52M | 5.54M | 6.41M |
| Cash from Investing | 857.30K | 2.24M | 3.52M | 5.54M | 6.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -41.10K | -82.20K | -123.30K | -109.60K | -82.20K |
| Issuance of Common Stock | 694.90K | 450.40K | 156.40K | -- | 0.00 |
| Repurchase of Common Stock | 0.00 | -76.20K | -81.10K | -262.10K | -262.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 311.00K | -10.20K | -7.00K | -7.00K | -7.00K |
| Cash from Financing | 964.80K | 281.80K | -55.00K | -378.70K | -351.30K |
| Foreign Exchange rate Adjustments | 400.00 | -100.00 | 500.00 | 600.00 | 2.20K |
| Miscellaneous Cash Flow Adjustments | -254.90K | -- | -- | -- | -- |
| Net Change in Cash | -23.30K | -16.50K | 32.90K | -327.60K | -300.80K |